Speech & ABA Therapy Franchising

The vendor opportunity at Speech & ABA Therapy Franchising

Speech & ABA Therapy Franchising presents a compact, early-stage opportunity for software vendors. The system comprises 8 total units, split evenly between 4 franchised and 4 company-owned locations. This small footprint means the total addressable market is limited, but the concentration of decision-making at the headquarters level in Texas can make for an efficient sales cycle. The brand operates in the health services sector, specifically speech and ABA therapy, a vertical with specialized software needs. All 8 mapped operators are single-unit owners, with no multi-unit operators on file, reinforcing that strategic technology decisions are likely made centrally rather than by a fragmented franchisee base.

Who controls software purchasing

Purchasing authority sits with the brand's founders and operational leadership. The 2024 FDD lists three Owner/Founders: Nafisa Obi, Amber Lister, and Camila Trevino. These individuals represent the ultimate decision-makers for any system-wide software adoption. For a vendor, the initial outreach should target this group. Supporting them are two key directors who would heavily influence a buying decision: Shelby Nelson, Director of Clinical Quality, and Jessica Camp, Director of Franchise Operations. Nelson is the likely champion for any clinical tool that impacts patient outcomes, while Camp would evaluate the operational impact on the franchise system. There is no CIO or dedicated technology buyer listed, which is typical for a system of this size.

Mandated and current tech stack

The technology landscape at Speech & ABA Therapy Franchising is defined by a single mandate: CentralReach. Disclosed in the 2024 FDD, CentralReach is the required practice management software. This platform is purpose-built for ABA and therapy providers, covering scheduling, billing, data collection, and clinical workflows. For a software vendor, this mandate is a critical piece of intelligence. Any product that overlaps with CentralReach's core functionality faces a high barrier to entry. Conversely, solutions that integrate with or complement CentralReach—such as specialized HR tools, advanced analytics, or family engagement platforms—may find a receptive audience. No other mandated or recommended technology systems were named in the FDD.

Procurement, renewals, and timing

Procurement processes at Speech & ABA Therapy Franchising are not clearly defined in the available FDD data. Item 8, which typically outlines designated or approved supplier requirements, provided no extract, leaving the procurement model unspecified. This ambiguity means vendors should be prepared for an ad-hoc evaluation process driven directly by the founders. Contract renewal timing is equally opaque. The initial franchise term length and Item 17 renewal signals were not disclosed in the 2024 FDD. Without these data points, there is no predictable window when the system might re-evaluate its core technology stack. A vendor's best strategy is to engage the HQ team directly with a clear value proposition that respects their existing CentralReach investment.

How to read the Speech & ABA Therapy Franchising FDD

The Franchise Disclosure Document is the foundational research tool for any vendor building a target account list. The 2024 FDD for Speech & ABA Therapy Franchising provides the unit counts, executive names, and technology mandates cited in this analysis. For a software seller, the most valuable sections are typically Item 1 (the business and its executives), Item 11 (franchisor's assistance, where tech mandates often appear), and Item 20 (outlet and franchisee tables). The full document is embedded below for your own review. When you are ready to move from a single FDD to a ranked, data-driven list of the best franchise systems to sell into, FranCloud can build that target list for you.